|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/50 |
| (11) | Patento numeris | 2775844 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12844605.1 |
| Europos patento paraiškos padavimo data | 2012-10-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/062263 |
| Data | 2012-10-26 |
| (87) | Numeris | WO 2013/063496 |
| Data | 2013-05-02 |
| (30) | Numeris | Data | Šalis |
| 201161552686 P | 2011-10-28 | US |
| (72) |
BENES, Cyril, H., US
BLAKEMORE, Stephen, J., US
BLANK, Jonathan, L., US
LIGHTCAP, Eric, S., US
MULLIGAN, George, J., US
SCHU, Matthew, C., US
SMITH, Peter, G., US
SETTLEMAN, Jeffrey E., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
Massachusetts General Hospital, 55 Fruit Street, Boston MA 02114, US |
| (54) | BIOMARKERS OF RESPONSE TO NAE INHIBITORS |
| BIOMARKERS OF RESPONSE TO NAE INHIBITORS |